Bionime (TPE:4737) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4737 Bionime Corp TPE:4737
63 GF Score
Price NT$58.30
GF Value NT$58.64
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bionime Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:4737
63GF Score
Bionime Corp TPE:4737
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bionime (TPE:4737) Overvalued in 2026?

Based on GuruFocus' analysis, Bionime stock appears to be undervalued. The current stock price of NT$58.30 is trading 0.6% below its estimated GF Value™ of NT$58.64. GuruFocus considers Bionime to be Fairly Valued.

Key valuation signals for TPE:4737:

  • Short Ratio:
  • GF Value™: NT$58.64 vs. price of NT$58.30 (0.6% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bionime Business Description

Address No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
63GF Score

Get the complete analysis for TPE:4737

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.30
Price
NT$58.64
GF Value